Inventor · disambiguated record
Hirak S. Basu
Also filed as: BASU HIRAK · BASU HIRAK S · BASU HIRAK SUBHRA · BLOKHIN ANDREI V
11 granted patents·11 pending applications·248 citations·filing 1993–2014
91Inventor score
Files withCELLGATE INC4PROGEN PHARMACEUTICALS INC3BASU HIRAK S2COLBY PHARMACEUTICAL COMPANY2FRYDMAN BENJAMIN2
Top patents by PatentIndex Score
22 records- 0194US6982351B2Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis thereforCELLGATE INC·Filed 2002·Granted Jan 3, 2006·38 cites·11 claims
- 0294US5541230ATherapeutic polyaminesUS HEALTH·Filed 1993·Granted Jul 30, 1996·77 cites·2 claims
- 0392US7453011B2Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis thereforPROGEN PHARMACEUTICALS INC·Filed 2007·Granted Nov 18, 2008·17 cites·14 claims
- 0491US7235695B2Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis thereforFRYDMAN BENJAMIN·Filed 2005·Granted Jun 26, 2007·17 cites·26 claims
- 0590US5880161ATherapeutic polyaminesUS HEALTH·Filed 1996·Granted Mar 9, 1999·48 cites·11 claims
- 0685US6794545B1Conformationally restricted polyamine analogs as disease therapiesSLIL BIOMEDICAL CORP·Filed 2000·Granted Sep 21, 2004·20 cites·20 claims
- 0784US7186825B2Conformationally restricted polyamine analogs as disease therapiesCELLGATE INC·Filed 2004·Granted Mar 6, 2007·15 cites·20 claims
- 0883US7026347B2Porphyrin-polyamine conjugates for cancer therapyCELLGATE INC·Filed 2003·Granted Apr 11, 2006·14 cites·16 claims
- 0965US8466130B2Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancersZARLING DAVID A·Filed 2009·Granted Jun 18, 2013·1 cites·3 claims
- 1060US2009124832A1Oligoamine compounds and derivatives thereof for cancer therapyPROGEN PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1157US2007161692A1Conformationally restricted polyamine analogs as disease therapiesCELLGATE INC·Filed 2006·Application pending·0 cites
- 1256US7491849B2Oligoamine compounds and derivatives thereof for cancer therapyPROGEN PHARMACEUTICALS INC·Filed 2004·Granted Feb 17, 2009·1 cites·21 claims
- 1348US2013338110A1Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancersWISCONSIN MED COLLEGE INC·Filed 2013·Application pending·0 cites
- 1446US2006276444A1Porphyrin-polyamine conjugates for cancer therapyFRYDMAN BENJAMIN·Filed 2006·Application pending·0 cites
- 1546US2003130356A1Oligoamine compounds and derivatives thereof for cancer therapySLIL BIOMEDICAL CORP·Filed 2002·Application pending·0 cites
- 1645US2005130949A1Cyclic polyamine compounds for cancer therapyFiled 2005·Application pending·0 cites
- 1745US2014179798A1N1,n4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and methods thereofWISCONSIN ALUMNI RES FOUND·Filed 2014·Application pending·0 cites
- 1840US2008114072A1N1,N4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and methods thereofBASU HIRAK S·Filed 2007·Application pending·0 cites
- 1936US2003072715A1Cyclic polyamine compounds for cancer therapyFiled 2001·Application pending·0 cites
- 2035US2011091931A1Methods and Kits for Determining Oxygen Free Radical (OFR) Levels in Animal and Human Tissues as a Prognostic Marker for Cancer and Other PathophysiologiesCOLBY PHARMACEUTICAL COMPANY·Filed 2010·Application pending·0 cites
- 2130US2010297262A1Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and usesCOLBY PHARMACEUTICAL COMPANY·Filed 2010·Application pending·0 cites
- 2228US9023837B2Androgen induced oxidative stress inhibitorsBASU HIRAK S·Filed 2011·Granted May 5, 2015·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Hirak S. Basu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →